Voglio sapere a riguardo di…

Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices Dated: August 20, 2021.
Lauren K. Roth, Acting Principal Associate Commissioner for Policy FR Doc. 202119096 Filed 9221; 8:45 am BILLING CODE 416401P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on Blood and Tissue Safety and Availability Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.
ACTION: Notice.
AGENCY:

The U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood and Tissue Safety and Availability ACBTSA will hold a virtual meeting. The meeting will be open to the public. The committee will discuss and vote on recommendations to improve the supply chain and data infrastructure that supports the blood industry, especially during public health emergencies. This meeting will build upon the presentations and discussions held during the 53rd ACBTSA meeting from August 1718, 2021.
DATES: The meeting will take place virtually on Thursday, September 23, 2021 from approximately 1:00 p.m.4:00
p.m. Eastern Time ET. Meeting times are tentative and subject to change. The confirmed times and agenda items for the meeting will be posted on the ACBTSA web page at https
www.hhs.gov/oidp/advisory-committee/
blood-tissue-safety-availability/
meetings/2021-09-23/index.html when this information becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer for the ACBTSA; Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Mary E. Switzer Building, 330
C Street SW, Suite L600, Washington, DC 20024. Email: ACBTSA@hhs.gov.
SUPPLEMENTARY INFORMATION: ACBTSA
is a discretionary Federal advisory committee. ACBTSA The Committee is governed by the provisions of the Federal Advisory Committee Act FACA, Public Law 92463, as amended 5 U.S.C. app, which sets forth standards for the formation and use of advisory committees. On the day of the meeting, please go to https
www.hhs.gov/live/index.html to view
lotter on DSK11XQN23PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

16:55 Sep 02, 2021

Jkt 253001

the meeting. The public will have an opportunity to present their views to the ACBTSA by submitting a written public comment. Comments should be pertinent to the meeting discussion.
Persons who wish to provide written public comment should review instructions at https www.hhs.gov/
oidp/advisory-committee/blood-tissuesafety-availability/meetings/2021-09-23/
index.html and respond by midnight September 16, 2021, ET. Written public comments will be accessible to the public on the ACBTSA web page prior to the meeting.
ACBTSA functions to provide advice to the Secretary through the Assistant Secretary for Health on a range of policy issues to include: 1 Identification of public health issues through surveillance of blood and tissue safety issues with national survey and data tools; 2 identification of public health issues that affect availability of blood, blood products, and tissues; 3 broad public health, ethical, and legal issues related to the safety of blood, blood products, and tissues; 4 the impact of various economic factors e.g., product cost and supply on safety and availability of blood, blood products, and tissues; 5 risk communications related to blood transfusion and tissue transplantation; and 6 identification of infectious disease transmission issues for blood, organs, blood stem cells and tissues. The Committee has met regularly since its establishment in 1997.
Dated: August 27, 2021.
James J. Berger, Designated Federal Officer, Advisory Committee on Blood and Tissue Safety and Availability, Office of Infectious Disease and HIV/AIDS Policy.
FR Doc. 202119026 Filed 9221; 8:45 am BILLING CODE 415028P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Federal Licensing of Office of Refugee Resettlement Facilities Request for Information Office of Refugee Resettlement ORR, Administration for Children and Families ACF, Department of Health and Human Services HHS.
ACTION: Request for information.
AGENCY:

The Unaccompanied Children UC Program is responsible for the administration of childcare facilities throughout the country that care for unaccompanied children arriving in the United States prior to those children being placed with viable sponsors in the
SUMMARY:

PO 00000

Frm 00046

Fmt 4703

Sfmt 4703

49549

United States. To inform a strategic and impactful plan for the administration of these facilities HHS is issuing this Request for Information RFI. The RFI
solicits specific input regarding options for a Federal licensure process to ensure continued program operations.
DATES: To be considered, public comments must be received electronically no later than October 4, 2021.
ADDRESSES: Public comments should be submitted online at http
www.regulations.gov. All submissions must be submitted to the Docket named ACF20210001 to Request for Information RFI from Non-Federal Stakeholders: Federal Licensing of ORR
Facilities. Comments submitted electronically, including attachments, will be posted to the docket unchanged and available to view by the public.
Evidence and information supporting your comment can be submitted as attachments. Please provide your contact information or organization name on the web-based form for possible follow up from HHS. There is a 5,000-character limit on comments and maximum number 10 of attached files and maximum size 10 MB of each attached file.
FOR FURTHER INFORMATION CONTACT:
Toby Biswas, Senior Supervisory Policy Counsel, Division of Policy and Procedures, Office of Refugee Resettlement, Administration for Children and Families, Department of Health and Human Services, Washington, DC, 202 2054440 or ucpolicy@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: ORR
facilities are currently administered through a nationwide network of grantee providers that care for unaccompanied children on a day-today basis. These facilities are subject to Federal ORR policies and regulations regarding their operations as well as applicable State-based licensure regulations regarding the operation of childcare facilities in each jurisdiction.
The Flores Settlement Agreement FSA generally requires that ORR
promptly place unaccompanied children into a State licensed child-care program. As of July 2021, ORR operates over 200 licensed care provider facilities in 22 states under approximately 50
separate grants executed under Cooperative Agreements between ORR
and the grantee care providers. Each State has its own State licensing standards.
The Director of ORR and the Secretary of HHS have broad authority to oversee policies for the care of unaccompanied children, including by identifying a
E:FRFM03SEN1.SGM

03SEN1